For example, Secretogranin II (SCG2) was overexpressed in melanoma tissues obtained from patients with a poor prognosis, and promoted immune escape by downregulating the expression of MHC-I ((major histocompatibility complex I)) [42]. This evidence concerns the gene SCG2 and melanoma.